AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
The grant was made in accordance with Nasdaq Listing Rule 5635(c)(4).
- The grant was made in accordance with Nasdaq Listing Rule 5635(c)(4).
- Vesting of the option award is subject to continued service with AVROBIO by the employee through the applicable vesting dates.
- AVROBIO is powered by our industry leading plato gene therapy platform, our foundation designed to deliver gene therapy worldwide.
- AVROBIO explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law.